Tela Sale Purchase Of Stock vs Stock Based Compensation Analysis

TELA Stock

USD 3.14 0.11 3.63%

Tela Bio financial indicator trend analysis is much more than just breaking down Tela Bio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tela Bio is a good investment. Please check the relationship between Tela Bio Sale Purchase Of Stock and its Stock Based Compensation accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.

Sale Purchase Of Stock vs Stock Based Compensation

Sale Purchase Of Stock vs Stock Based Compensation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tela Bio Sale Purchase Of Stock account and Stock Based Compensation. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Tela Bio's Sale Purchase Of Stock and Stock Based Compensation is -0.63. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Stock Based Compensation in the same time period over historical financial statements of Tela Bio, assuming nothing else is changed. The correlation between historical values of Tela Bio's Sale Purchase Of Stock and Stock Based Compensation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Tela Bio are associated (or correlated) with its Stock Based Compensation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Stock Based Compensation has no effect on the direction of Sale Purchase Of Stock i.e., Tela Bio's Sale Purchase Of Stock and Stock Based Compensation go up and down completely randomly.

Correlation Coefficient

-0.63

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Sale Purchase Of Stock

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Most indicators from Tela Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tela Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.As of November 29, 2024, Selling General Administrative is expected to decline to about 10.6 M. In addition to that, Issuance Of Capital Stock is expected to decline to about 35.7 M

	2023	2024 (projected)
Depreciation And Amortization	808K	850.9K
Interest Income	3.3M	2.6M

Depreciation And Amortization Interest Income

Tela Bio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		0.92	0.79	0.65	0.97	-0.97	0.96	0.45	-0.41	-0.48	-0.84	0.07	0.97	0.85	-0.61	-0.41	0.92	0.97	0.76	0.88	0.91	-0.93	0.78	0.79	0.94	-0.91
Short Long Term Debt Total	0.92		0.89	0.81	0.82	-0.95	0.82	0.54	-0.43	-0.11	-0.87	0.32	0.83	0.97	-0.44	-0.43	1.0	0.83	0.81	0.87	1.0	-0.76	0.89	0.66	0.89	-0.73
Other Current Liab	0.79	0.89		0.97	0.69	-0.77	0.68	0.74	-0.52	0.03	-0.91	0.11	0.67	0.95	-0.28	-0.52	0.88	0.63	0.88	0.94	0.91	-0.65	0.97	0.53	0.9	-0.6
Total Current Liabilities	0.65	0.81	0.97		0.56	-0.66	0.55	0.79	-0.55	0.23	-0.86	0.17	0.5	0.91	-0.14	-0.55	0.8	0.47	0.87	0.89	0.83	-0.52	0.96	0.39	0.8	-0.47
Total Stockholder Equity	0.97	0.82	0.69	0.56		-0.94	1.0	0.45	-0.41	-0.55	-0.81	-0.01	0.95	0.74	-0.72	-0.41	0.82	0.96	0.74	0.85	0.8	-0.99	0.72	0.83	0.92	-0.98
Other Liab	-0.97	-0.95	-0.77	-0.66	-0.94		-0.94	-0.45	0.43	0.32	0.85	-0.28	-0.92	-0.88	0.59	0.43	-0.95	-0.93	-0.77	-0.84	-0.93	0.9	-0.79	-0.78	-0.9	0.89
Net Tangible Assets	0.96	0.82	0.68	0.55	1.0	-0.94		0.44	-0.4	-0.56	-0.81	-0.02	0.95	0.73	-0.73	-0.4	0.82	0.95	0.73	0.84	0.79	-0.99	0.71	0.83	0.92	-0.99
Property Plant And Equipment Net	0.45	0.54	0.74	0.79	0.45	-0.45	0.44		-0.85	0.22	-0.84	-0.16	0.32	0.66	-0.03	-0.85	0.52	0.29	0.91	0.73	0.53	-0.42	0.76	0.16	0.61	-0.38
Current Deferred Revenue	-0.41	-0.43	-0.52	-0.55	-0.41	0.43	-0.4	-0.85		-0.09	0.75	0.07	-0.34	-0.49	-0.19	1.0	-0.42	-0.33	-0.82	-0.53	-0.41	0.35	-0.48	-0.21	-0.44	0.33
Net Debt	-0.48	-0.11	0.03	0.23	-0.55	0.32	-0.56	0.22	-0.09		0.09	0.5	-0.64	0.04	0.54	-0.09	-0.11	-0.63	0.01	-0.2	-0.1	0.56	0.08	-0.55	-0.35	0.59
Retained Earnings	-0.84	-0.87	-0.91	-0.86	-0.81	0.85	-0.81	-0.84	0.75	0.09		-0.03	-0.74	-0.89	0.35	0.75	-0.87	-0.72	-0.98	-0.92	-0.86	0.77	-0.91	-0.61	-0.91	0.74
Accounts Payable	0.07	0.32	0.11	0.17	-0.01	-0.28	-0.02	-0.16	0.07	0.5	-0.03		-0.04	0.3	0.13	0.07	0.33	0.03	0.01	0.0	0.32	0.04	0.14	0.05	-0.05	0.05
Cash	0.97	0.83	0.67	0.5	0.95	-0.92	0.95	0.32	-0.34	-0.64	-0.74	-0.04		0.73	-0.62	-0.34	0.84	0.99	0.64	0.78	0.82	-0.9	0.64	0.82	0.88	-0.9
Non Current Assets Total	0.85	0.97	0.95	0.91	0.74	-0.88	0.73	0.66	-0.49	0.04	-0.89	0.3	0.73		-0.33	-0.49	0.97	0.72	0.86	0.9	0.98	-0.68	0.95	0.51	0.87	-0.64
Non Currrent Assets Other	-0.61	-0.44	-0.28	-0.14	-0.72	0.59	-0.73	-0.03	-0.19	0.54	0.35	0.13	-0.62	-0.33		-0.19	-0.44	-0.63	-0.25	-0.46	-0.4	0.78	-0.4	-0.63	-0.61	0.8
Other Assets	-0.41	-0.43	-0.52	-0.55	-0.41	0.43	-0.4	-0.85	1.0	-0.09	0.75	0.07	-0.34	-0.49	-0.19		-0.42	-0.33	-0.82	-0.53	-0.41	0.35	-0.48	-0.21	-0.44	0.33
Long Term Debt	0.92	1.0	0.88	0.8	0.82	-0.95	0.82	0.52	-0.42	-0.11	-0.87	0.33	0.84	0.97	-0.44	-0.42		0.83	0.79	0.86	1.0	-0.76	0.88	0.67	0.89	-0.73
Cash And Short Term Investments	0.97	0.83	0.63	0.47	0.96	-0.93	0.95	0.29	-0.33	-0.63	-0.72	0.03	0.99	0.72	-0.63	-0.33	0.83		0.63	0.76	0.82	-0.91	0.62	0.8	0.86	-0.91
Net Receivables	0.76	0.81	0.88	0.87	0.74	-0.77	0.73	0.91	-0.82	0.01	-0.98	0.01	0.64	0.86	-0.25	-0.82	0.79	0.63		0.9	0.79	-0.7	0.89	0.49	0.84	-0.67
Common Stock Shares Outstanding	0.88	0.87	0.94	0.89	0.85	-0.84	0.84	0.73	-0.53	-0.2	-0.92	0.0	0.78	0.9	-0.46	-0.53	0.86	0.76	0.9		0.88	-0.83	0.94	0.63	0.97	-0.8
Long Term Debt Total	0.91	1.0	0.91	0.83	0.8	-0.93	0.79	0.53	-0.41	-0.1	-0.86	0.32	0.82	0.98	-0.4	-0.41	1.0	0.82	0.79	0.88		-0.74	0.89	0.64	0.89	-0.71
Non Current Liabilities Total	-0.93	-0.76	-0.65	-0.52	-0.99	0.9	-0.99	-0.42	0.35	0.56	0.77	0.04	-0.9	-0.68	0.78	0.35	-0.76	-0.91	-0.7	-0.83	-0.74		-0.7	-0.83	-0.9	1.0
Inventory	0.78	0.89	0.97	0.96	0.72	-0.79	0.71	0.76	-0.48	0.08	-0.91	0.14	0.64	0.95	-0.4	-0.48	0.88	0.62	0.89	0.94	0.89	-0.7		0.51	0.9	-0.65
Other Current Assets	0.79	0.66	0.53	0.39	0.83	-0.78	0.83	0.16	-0.21	-0.55	-0.61	0.05	0.82	0.51	-0.63	-0.21	0.67	0.8	0.49	0.63	0.64	-0.83	0.51		0.76	-0.83
Other Stockholder Equity	0.94	0.89	0.9	0.8	0.92	-0.9	0.92	0.61	-0.44	-0.35	-0.91	-0.05	0.88	0.87	-0.61	-0.44	0.89	0.86	0.84	0.97	0.89	-0.9	0.9	0.76		-0.88
Total Liab	-0.91	-0.73	-0.6	-0.47	-0.98	0.89	-0.99	-0.38	0.33	0.59	0.74	0.05	-0.9	-0.64	0.8	0.33	-0.73	-0.91	-0.67	-0.8	-0.71	1.0	-0.65	-0.83	-0.88

Click cells to compare fundamentals

Tela Bio Account Relationship Matchups

Tela Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	67.9M	86.5M	62.5M	67.9M	78.0M	63.7M
Short Long Term Debt Total	30.2M	30.8M	31.5M	40.3M	41.1M	33.0M
Other Current Liab	3.5M	6.0M	8.2M	10.5M	14.7M	8.0M
Total Current Liabilities	6.7M	6.6M	10.6M	12.4M	17.0M	10.8M
Total Stockholder Equity	31.0M	49.0M	20.1M	14.3M	18.9M	19.8M
Net Tangible Assets	28.1M	46.4M	17.8M	11.8M	13.6M	14.3M
Property Plant And Equipment Net	677K	626K	1.2M	2.9M	3.9M	4.1M
Net Debt	(15.1M)	(43.6M)	(12.4M)	(2.1M)	(5.6M)	(5.9M)
Retained Earnings	(167.9M)	(196.7M)	(229.9M)	(274.2M)	(320.9M)	(336.9M)
Accounts Payable	3.2M	652K	2.4M	1.5M	1.7M	1.6M
Cash	45.3M	74.4M	43.9M	42.0M	46.7M	44.2M
Non Current Assets Total	3.6M	3.2M	3.5M	5.4M	6.3M	4.3M
Non Currrent Assets Other	(3.6M)	(3.2M)	(3.5M)	(5.4M)	265K	278.3K
Long Term Debt	30.2M	30.8M	31.5M	39.9M	40.5M	32.4M
Cash And Short Term Investments	54.6M	74.4M	43.9M	42.0M	46.7M	45.6M
Net Receivables	2.8M	2.7M	4.2M	6.6M	9.7M	10.2M
Common Stock Shares Outstanding	11.4M	12.9M	14.5M	16.3M	22.9M	14.3M
Long Term Debt Total	31.4M	30.2M	31.5M	39.9M	45.9M	30.4M
Liabilities And Stockholders Equity	67.9M	86.5M	62.5M	67.9M	78.0M	63.7M
Non Current Liabilities Total	30.2M	30.8M	31.9M	41.1M	42.2M	51.4M
Inventory	4.6M	3.9M	7.7M	11.8M	13.2M	7.4M
Other Current Assets	2.3M	4.5M	6.5M	2.0M	2.1M	2.8M
Other Stockholder Equity	130.9M	245.7M	250.1M	288.4M	339.7M	198.1M
Total Liab	37.0M	37.4M	42.4M	53.6M	59.2M	59.2M
Net Invested Capital	61.2M	79.9M	51.6M	54.2M	59.4M	62.4M
Property Plant And Equipment Gross	677K	626K	4.9M	2.9M	8.3M	8.7M
Total Current Assets	64.3M	83.2M	59.1M	62.4M	71.7M	59.5M
Accumulated Other Comprehensive Income	(19K)	(71K)	(52K)	150K	91K	95.6K
Non Current Liabilities Other	5K	4K	380K	1.2M	1.7M	1.8M
Net Working Capital	57.6M	76.6M	48.5M	50.0M	54.8M	48.6M
Common Stock	11K	14K	15K	19K	24K	15.2K
Property Plant Equipment	677K	626K	1.2M	1.7M	1.9M	1.1M
Capital Stock	11K	14K	15K	19K	24K	15.2K
Intangible Assets	2.9M	2.6M	2.3M	2.5M	2.1M	2.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Tela Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tela Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tela Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tela Bio Stock:

How To Invest In Tela

Details

Is Tela Stock a good investment?

Details

What is Tela Bio's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.

You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.69)

Revenue Per Share

2.789

Quarterly Revenue Growth

0.259

Return On Assets

(0.41)

Return On Equity

(3.42)

The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tela Sale Purchase Of Stock vs Stock Based Compensation Analysis

Sale Purchase Of Stock vs Stock Based Compensation

Sale Purchase Of Stock vs Stock Based Compensation Correlation Analysis

Correlation Coefficient

Sale Purchase Of Stock

Stock Based Compensation

Tela Bio fundamental ratios Correlations

Tela Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Tela Bio fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Long Term Debt Total	+ 1.0	Short Long Term Debt Total
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Other Assets	+ 1.0	Current Deferred Revenue
Long Term Debt Total	+ 1.0	Long Term Debt
Total Liab	+ 1.0	Non Current Liabilities Total

Total Liab	- 0.99	Net Tangible Assets
Non Current Liabilities Total	- 0.99	Net Tangible Assets
Non Current Liabilities Total	- 0.99	Total Stockholder Equity
Net Receivables	- 0.98	Retained Earnings
Total Liab	- 0.98	Total Stockholder Equity
Other Liab	- 0.97	Total Assets